GlobalPost interviews director of WHO Stop TB Department about future of global response

NewsGuard 100/100 Score

In an interview with GlobalPost's "Global Pulse" blog, Mario Raviglione, director of the WHO's Stop TB Department, explains "why the fight against [tuberculosis (TB)] is at a crossroads." Because of advances in diagnostics and treatment, "we have a possibility here of envisioning a much brighter future for TB care and control over the next few decades," he says, according to the interview transcript. "On the other hand, we have a financial gap that we are estimating at about $3 billion out of the $8 billion that are necessary for care and control efforts in countries, plus another $1.4 billion gap in the area of research," he continues. According to the transcript, Raviglione addresses "why the funding gap exists, what would help reduce it, and what's at stake as we choose a path forward" (Judem, 11/1).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Microfluidic chips advance neurodegenerative disease research